Prolactinoma-associated obesity treated with bupropion and methylphenidate.
作者信息
Terock Jan, Hohagen Fritz, Petersen Dirk, Zurowski Bartosz
机构信息
Department of Psychiatry and Psychotherapy, University of Lübeck, Ratzeburger Allee 160, Lübeck, 23538, Germany.
出版信息
Ther Adv Psychopharmacol. 2013 Jun;3(3):177-80. doi: 10.1177/2045125312467345.
Abstract
摘要
相似文献
1
Prolactinoma-associated obesity treated with bupropion and methylphenidate.
Ther Adv Psychopharmacol. 2013 Jun;3(3):177-80. doi: 10.1177/2045125312467345.
2
Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans.
Exp Clin Psychopharmacol. 1998 Feb;6(1):32-44. doi: 10.1037//1064-1297.6.1.32.
3
Psychological and physiological effects of bupropion compared to methylphenidate after prolonged administration in healthy volunteers (NCT00285155).
Eur J Clin Pharmacol. 2013 Apr;69(4):779-87. doi: 10.1007/s00228-012-1418-z. Epub 2012 Oct 9.
4
Bupropion versus methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder: randomized double-blind study.
Hum Psychopharmacol. 2012 Jul;27(4):411-8. doi: 10.1002/hup.2242.
5
Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder.
J Am Acad Child Adolesc Psychiatry. 1995 May;34(5):649-57. doi: 10.1097/00004583-199505000-00017.
6
Bupropion SR vs. methylphenidate vs. placebo for attention deficit hyperactivity disorder in adults.
Ann Clin Psychiatry. 2001 Sep;13(3):129-34. doi: 10.1023/a:1012239823148.
7
Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis with focus on bupropion.
J Affect Disord. 2015 Jun 1;178:149-59. doi: 10.1016/j.jad.2015.03.006. Epub 2015 Mar 13.
8
A Systematic Review of the Use of Bupropion for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.
J Child Adolesc Psychopharmacol. 2017 Mar;27(2):112-116. doi: 10.1089/cap.2016.0124. Epub 2016 Nov 4.
9
Pharmacokinetic interactions between cyclosporine and bupropion or methylphenidate.
J Child Adolesc Psychopharmacol. 2001 Summer;11(2):193-8. doi: 10.1089/104454601750284117.
10
Effects of methylphenidate and bupropion on DHEA-S and cortisol plasma levels in attention-deficit hyperactivity disorder.
Child Psychiatry Hum Dev. 2008 Jun;39(2):201-9. doi: 10.1007/s10578-007-0081-6. Epub 2007 Aug 31.
本文引用的文献
1
Effects of methylphenidate on weight gain and food intake in hypothalamic obesity.
Front Endocrinol (Lausanne). 2011 Dec 14;2:78. doi: 10.3389/fendo.2011.00078. eCollection 2011.
2
Randomized pilot study of cabergoline, a dopamine receptor agonist: effects on body weight and glucose tolerance in obese adults.
Diabetes Obes Metab. 2012 Apr;14(4):335-40. doi: 10.1111/j.1463-1326.2011.01534.x. Epub 2011 Dec 27.
3
BMI and metabolic profile in patients with prolactinoma before and after treatment with dopamine agonists.
Obesity (Silver Spring). 2011 Apr;19(4):800-5. doi: 10.1038/oby.2010.150. Epub 2010 Jun 17.
4
Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats.
Nat Neurosci. 2010 May;13(5):635-41. doi: 10.1038/nn.2519. Epub 2010 Mar 28.
5
Comparison of combined bupropion and naltrexone therapy for obesity with monotherapy and placebo.
J Clin Endocrinol Metab. 2009 Dec;94(12):4898-906. doi: 10.1210/jc.2009-1350. Epub 2009 Oct 21.
6
Attenuation of cue-induced smoking urges and brain reward activity in smokers treated successfully with bupropion.
J Psychopharmacol. 2010 Jun;24(6):829-38. doi: 10.1177/0269881109105456. Epub 2009 Jul 31.
7
Rational design of a combination medication for the treatment of obesity.
Obesity (Silver Spring). 2009 Jan;17(1):30-9. doi: 10.1038/oby.2008.461. Epub 2008 Nov 6.
8
Cabergoline-induced psychotic exacerbation in schizophrenic patients.
Gen Hosp Psychiatry. 2008 Jul-Aug;30(4):378-80. doi: 10.1016/j.genhosppsych.2007.11.002.
9
Widespread reward-system activation in obese women in response to pictures of high-calorie foods.
Neuroimage. 2008 Jun;41(2):636-47. doi: 10.1016/j.neuroimage.2008.02.031. Epub 2008 Mar 4.
10
Dopaminergic tone and obesity: an insight from prolactinomas treated with bromocriptine.
Eur J Endocrinol. 2002 Jul;147(1):77-84. doi: 10.1530/eje.0.1470077.
Zotero 插件